Search Results

Displaying 10 of 617 articles for (Title, Keywords or Abstract contains ‘MDR-TB’)

Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment
Authors:	Kelly, A. M.; Smith, B.; Luo, Z.; Given, B.; Wehrwein, T.; Master, I.; Farley, J. E.
Source:	The International Journal of Tuberculosis and Lung Disease, Volume 20, Number 4, 1 April 2016, pp. 442-447(6)
Publisher:	International Union Against Tuberculosis and Lung Disease

Favourites:
ADD

Redefining MDR-TB transmission ‘hot spots’ [Counterpoint]
Authors:	Becerra, M. C.; Bayona, J.; Freeman, J.; Farmer, P. E.; Kim, J. Y.
Source:	The International Journal of Tuberculosis and Lung Disease, Volume 4, Number 5, May 2000, pp. 387-394(8)
Publisher:	International Union Against Tuberculosis and Lung Disease

Favourites:
ADD

Surveillance for MDR-TB: is there an obligation to ensure treatment for individuals identified with MDR-TB? [Unresolved issues]
Authors:	Edginton, M. E.; Miller, D. L.; Burney, P.; El Sony, A. I.; Lwilla, F. I.; O'Brien, R.; Roldan, M. B.; Roldan, A.; Srinath, S.
Source:	The International Journal of Tuberculosis and Lung Disease, Volume 14, Number 9, September 2010, pp. 1094-1096(3)
Publisher:	International Union Against Tuberculosis and Lung Disease

Favourites:
ADD

Outcome of treatment of MDR-TB patients with standardised regimens, Iran, 2002–2006
Authors:	Masjedi, M. R.; Tabarsi, P.; Chitsaz, E.; Baghaei, P.; Mirsaeidi, M.; Amiri, M. V.; Farnia, P.; Javanmard, P.; Mansouri, D.; Velayati, A. A.
Source:	The International Journal of Tuberculosis and Lung Disease, Volume 12, Number 7, July 2008, pp. 750-755(6)
Publisher:	International Union Against Tuberculosis and Lung Disease

Favourites:
ADD

Management and treatment outcomes of patients enrolled in MDR-TB treatment in Viet Nam
Authors:	Phuong, N. T. M.; Nhung, N. V.; Hoa, N. B.; Thuy, H. T.; Takarinda, K. C.; Tayler-Smith, K.; Harries, A. D.
Source:	Public Health Action, Volume 6, Number 1, 21 March 2016, pp. 25-31(7)
Publisher:	International Union Against Tuberculosis and Lung Disease

Favourites:
ADD

Methodological considerations in clinical trials for new MDR-TB treatment regimens
Author:	Phillips, P. P. J.
Source:	The International Journal of Tuberculosis and Lung Disease, Volume 20, Supplement 1, 1 December 2016, pp. S4-S7(4)
Publisher:	International Union Against Tuberculosis and Lung Disease

Favourites:
ADD

Representative drug susceptibility patterns for guiding design of retreatment regimens for MDR-TB
Authors:	Rich, M. L.; Socci, A. R.; Mitnick, C. D.; Nardell, E. A.; Becerra, M. C.; Bonilla, C.; Bayona, J.; Seung, K. J.; Furin, J.; Farmer, P. E.; Mukherjee, J. S.
Source:	The International Journal of Tuberculosis and Lung Disease, Volume 10, Number 3, March 2006, pp. 290-296(7)
Publisher:	International Union Against Tuberculosis and Lung Disease

Favourites:
ADD

Bayesian adaptive randomization in a clinical trial to identify new regimens for MDR-TB: the endTB trial
Authors:	Cellamare, M.; Milstein, M.; Ventz, S.; Baudin, E.; Trippa, L.; Mitnick, C. D.
Source:	The International Journal of Tuberculosis and Lung Disease, Volume 20, Supplement 1, 1 December 2016, pp. S8-S12(5)
Publisher:	International Union Against Tuberculosis and Lung Disease

Favourites:
ADD

Management of child MDR-TB contacts across countries in the WHO European Region: a survey of current practice
Authors:	Turkova, A.; Tebruegge, M.; Brinkmann, F.; Tsolia, M.; Mouchet, F.; Kampmann, B.; Seddon, J. A.
Source:	The International Journal of Tuberculosis and Lung Disease, Volume 21, Number 7, 1 July 2017, pp. 774-777(4)
Publisher:	International Union Against Tuberculosis and Lung Disease

Favourites:
ADD

The role of the nurse in the community-based treatment of multidrug-resistant tuberculosis (MDR-TB)
Authors:	Palacios, E.; Guerra, D.; Llaro, K.; Chalco, K.; Sapag, R.; Furin, J.
Source:	The International Journal of Tuberculosis and Lung Disease, Volume 7, Number 4, April 2003, pp. 343-346(4)
Publisher:	International Union Against Tuberculosis and Lung Disease

Favourites:
ADD

Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more

Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment